Status: Recruiting
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
A Phase 1/2a Study of DB-2304 in Healthy Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus
Participants needed: 148
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: DualityBio Inc.Updated: Jun 2, 2026Locations: 7
Eligibility criteria
Participants who fully understand the purpose, nature, method, and potential adv... [+8]
Evidence or history of clinically significant diseases. [+9]